Franco Indian

GRILINCTUS-L^® Syrup

Each 5 ml suspension contains:

Cough is an important protective reflex and a universal symptom in health, but when persistent, it is the most common reason why patients seek medical attention. In epidemiological studies, cough is reported up to 40% of the population at any one time. Cough is associated with significantly impaired health-related quality of life, regardless of whether it is acute or chronic. Sleep disturbance, nausea, chest pain and lethargy occur frequently and patients with chronic cough often experience social embarrassment, urinary incontinence and low mood. There is a significant economic cost for the individual with cough when it leads to absence from work and lost productivity. Hence, the need for an antitussive cough syrup.
Levocloperastine is a novel antitussive with a pharmacological profile distinct from that of the racemic DL-cloperastine. It is the levorotatory isomer of DL-cloperastine. It has a selective inhibiting action on the cough bulbar centre, an action on the peripheral stimuli that induce the cough reflex by inhibiting the inflammatory process mediators and an anti-bronchospasm effect. This dual mechanism of action (both central and peripheral) makes levocloperastine fendizoate effective in the treatment of cough associated with many chronic and acute conditions in patients of all ages.